文献速递临床试验与 GCP基础与转化研究

持续输注高渗盐水对中重度创伤性脑损伤患者6个月神经功能结局的影响:COBI随机临床试验

Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients With Traumatic Brain Injury: The COBI Randomized Clinical Trial.
PubMed 文献 · JAMA · 2021-01-01

COBI多中心随机临床试验在法国9个ICU纳入370例中重度创伤性脑损伤患者,比较持续输注20%高渗盐水联合标准治疗与单纯标准治疗。结果显示6个月GOS-E评分的调整共同OR为1.02(95%CI 0.71-1.47;P=.92),无显著差异;颅内高压发生率和6个月死亡率等12项次要结局中10项无显著差异,但置信区间较宽,研究可能把握度不足。

要点

  • 持续输注20%高渗盐水未显著改善中重度TBI患者6个月神经功能结局。
  • 颅内高压发生率干预组33.7%、对照组36.3%,差异无统计学意义。
  • 6个月死亡率干预组15.9%、对照组20.8%,差异无统计学意义。

核心结论

  • 在中重度创伤性脑损伤患者中,与标准治疗相比,持续输注20%高渗盐水未显著改善6个月神经功能状态。
  • 研究置信区间较宽,可能把握度不足以检测临床重要差异。

研究设计与样本

  • 多中心随机临床试验,在法国9个重症监护病房开展。
  • 纳入370例中重度创伤性脑损伤成人患者,2017年10月至2019年8月招募,2020年2月完成随访。
  • 干预组185例接受持续输注20%高渗盐水联合标准治疗,对照组185例仅接受标准治疗。
  • 20%高渗盐水输注48小时,若患者仍存在颅内高压风险则延长。
  • 主要结局为6个月扩展格拉斯哥结局量表(GOS-E)评分,由盲法评估者集中获取,采用序数逻辑回归调整预设预后因素。

主要发现

  • 6个月GOS-E评分的调整共同OR为1.02(95%CI 0.71-1.47;P=.92)。
  • 12项次要结局中10项无显著差异。
  • 颅内高压发生率干预组62例(33.7%),对照组66例(36.3%);绝对差异-2.6%(95%CI -12.3%至7.2%);OR 0.80(95%CI 0.51-1.26)。
  • 6个月死亡率干预组29例(15.9%),对照组37例(20.8%);绝对差异-4.9%(95%CI -12.8%至3.1%);风险比0.79(95%CI 0.48-1.28)。
  • 370例随机患者中位年龄44岁(四分位距27-59),女性77例(20.2%),359例(97%)完成试验。

临床怎么用

  • 对于中重度创伤性脑损伤患者,持续输注20%高渗盐水不能作为常规改善6个月神经功能结局的干预措施。
  • 临床决策时应结合本研究置信区间较宽、把握度有限的局限性综合判断。

局限性

  • 置信区间较宽,研究可能把握度不足以检测临床重要差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Fluid therapy is an important component of care for patients with traumatic brain injury, but whether it modulates clinical outcomes remains unclear. OBJECTIVE: To determine whether continuous infusion of hypertonic saline solution improves neurological outcome at 6 months in patients with traumatic brain injury. DESIGN, SETTING, AND PARTICIPANTS: Multicenter randomized clinical trial conducted in 9 intensive care units in France, including 370 patients with moderate to severe traumatic brain injury who were recruited from October 2017 to August 2019. Follow-up was completed in February 2020. INTERVENTIONS: Adult patients with moderate to severe traumatic brain injury were randomly assigned to receive continuous infusion of 20% hypertonic saline solution plus standard care (n = 185) or standard care alone (controls; n = 185). The 20% hypertonic saline solution was administered for 48 hours or longer if patients remained at risk of intracranial hypertension. MAIN OUTCOMES AND MEASURES: The primary outcome was Extended Glasgow Outcome Scale (GOS-E) score (range, 1-8, with lower scores indicating worse functional outcome) at 6 months, obtained centrally by blinded assessors and analyzed with ordinal logistic regression adjusted for prespecified prognostic factors (with a common odds ratio [OR] >1.0 favoring intervention). There were 12 secondary outcomes measured at multiple time points, including development of intracranial hypertension and 6-month mortality. RESULTS: Among 370 patients who were randomized (median age, 44 [interquartile range, 27-59] years; 77 [20.2%] women), 359 (97%) completed the trial. The adjusted common OR for the GOS-E score at 6 months was 1.02 (95% CI, 0.71-1.47; P = .92). Of the 12 secondary outcomes, 10 were not significantly different. Intracranial hypertension developed in 62 (33.7%) patients in the intervention group and 66 (36.3%) patients in the control group (absolute difference, -2.6% [95% CI, -12.3% to 7.2%]; OR, 0.80 [95% CI, 0.51-1.26]). There was no significant difference in 6-month mortality (29 [15.9%] in the intervention group vs 37 [20.8%] in the control group; absolute difference, -4.9% [95% CI, -12.8% to 3.1%]; hazard ratio, 0.79 [95% CI, 0.48-1.28]). CONCLUSIONS AND RELEVANCE: Among patients with moderate to severe traumatic brain injury, treatment with continuous infusion of 20% hypertonic saline compared with standard care did not result in a significantly better neurological status at 6 months. However, confidence intervals for the findings were wide, and the study may have had limited power to detect a clinically important difference. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03143751.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Roquilly A, Moyer JD, Huet O, et al. Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients With Traumatic Brain Injury: The COBI Randomized Clinical Trial. JAMA. 2021. PMID: 34032829. doi:10.1001/jama.2021.5561

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。